Weakness in the domestic eyewear retail market
First written in FY2016-Q3. 15 of 31 entries say "Restated". Latest entry: FY2025.
0 other companies' latest entry also says "Mitigated".
- FY2025MitigatedAnnual report
「The domestic eyewear retail market is expanding as consumers shift from low-priced products to higher-value-added products, driving up the unit price of complete eyewear.」
The explanation shifted from market contraction and weakness to stable market expansion driven by a shift toward higher-value-added products and rising unit prices. - FY2025-H1RestatedAnnual report
「The domestic eyewear retail market (prescription eyewear) showed signs of recovering toward its pre-COVID-19 level.」
The explanation that the domestic eyewear retail market was recovering toward its pre-COVID-19 level continued. - FY2024-Q3RestatedAnnual report
「The domestic eyewear retail market (prescription eyewear) showed signs of recovering toward its pre-COVID-19 level as the impact of COVID-19 subsided.」
The disclosure reconfirmed that the domestic eyewear retail market was recovering toward its pre-COVID-19 level after the impact of COVID-19 subsided. - FY2024-Q2RestatedAnnual report
「The domestic eyewear retail market (prescription eyewear) showed signs of recovering toward its pre-COVID-19 level as the impact of COVID-19 subsided.」
The explanation that the domestic eyewear retail market was recovering toward its pre-COVID-19 level continued after the impact of the pandemic subsided. - FY2024-Q1MitigatedAnnual report
「The domestic eyewear retail market (prescription eyewear) showed signs of recovering toward its pre-COVID-19 level as the impact of COVID-19 subsided.」
As the impact of COVID-19 subsided, the domestic eyewear retail market showed signs of returning to its pre-COVID-19 level. - FY2023MitigatedAnnual report
「Overall market demand declined temporarily due to the impact of COVID-19 and other factors, but signs of a gradual recovery have recently emerged.」
The domestic eyewear retail market was affected by lower demand due to COVID-19, but was described as gradually recovering recently. The analysis of operating results, however, stated that it had not yet returned to its pre-COVID-19 level. - FY2023-Q3RestatedAnnual report
「The domestic eyewear retail market (prescription eyewear) has continued to fluctuate from period to period year on year due to the impact of COVID-19 and has not yet recovered to its pre-COVID-19 level.」
The domestic eyewear retail market continued to fluctuate and remained below its pre-COVID-19 level. - FY2023-Q2WorsenedAnnual report
「The domestic eyewear retail market (prescription eyewear) had continued to fluctuate from period to period year on year due to the impact of COVID-19, but has recently declined and has not yet recovered to its pre-COVID-19 level.」
While market conditions continued to fluctuate, the market recently turned down and remained below its pre-COVID-19 level, indicating greater weakness in the domestic market. - FY2023-Q1MitigatedAnnual report
「The domestic eyewear retail market (prescription eyewear) has continued to fluctuate from period to period year on year due to the impact of COVID-19. Although signs of recovery have recently emerged, the market has not yet recovered to its pre-COVID-19 level.」
Although fluctuations continued, the disclosure changed to indicate signs of recovery. The market nevertheless remained below its pre-COVID-19 level. - FY2022-Q3RestatedAnnual report
「The domestic eyewear retail market has continued to fluctuate from period to period year on year due to the impact of COVID-19.」
The domestic eyewear retail market continued to fluctuate from period to period year on year. - FY2022-Q2Market conditions fluctuating without a clear trendAnnual report
「The domestic eyewear retail market has continued to fluctuate from period to period year on year due to the impact of COVID-19.」
The description changed from a continuing year-on-year decline to market conditions fluctuating from period to period. - FY2022-Q1RestatedAnnual report
「Although declarations of a state of emergency and other measures introduced in response to the spread of COVID-19 have been lifted, the domestic eyewear retail market (prescription eyewear) has continued to decline year on year.」
The domestic eyewear retail market continued to decline year on year even after declarations of a state of emergency and other measures were lifted. - FY2021-Q3MitigatedAnnual report
「The market grew year on year, but remained below the level of two years earlier.」
Although the market size turned positive year on year, it remained below the level before the spread of COVID-19, indicating only a partial recovery from its previous weakness. - FY2021-Q2RestatedAnnual report
「The domestic eyewear retail market (prescription eyewear) has continued to decline recently, partly due to the backlash from last year's consumption-tax-rate increase.」
The negative trend in the domestic eyewear retail market continued against the backdrop of the backlash from the consumption-tax-rate increase. - FY2021-Q1WorsenedAnnual report
「The domestic eyewear retail market (prescription eyewear) has continued to decline recently, partly due to the backlash from last year's consumption-tax-rate increase.」
The negative trend in the domestic eyewear retail market continued, driven in part by the backlash from the previous year's consumption-tax-rate increase. - FY2020ReframedAnnual report
「Meanwhile, unit prices for complete eyewear, including frames and lenses, have continued to decline year after year, leaving the overall market size broadly flat.」
The explanation shifted from recent year-on-year declines and weakness to a structural description of a mature market: volumes are increasing, but unit prices are falling and the overall market is broadly flat. - FY2020-Q3WorsenedAnnual report
「In addition to the continuing year-on-year decline in the domestic eyewear retail market (prescription eyewear) since March 2016, the market has recently been significantly affected by COVID-19.」
The disclosure adds that the market has been significantly affected by COVID-19, worsening the weakness in the domestic market. quantified: false; materialized: true. - FY2020-Q2Signs of changing demandAnnual report
「Although the domestic eyewear retail market (prescription eyewear) has continued to decline year on year since March 2016, signs of changing demand have recently emerged, partly due to front-loaded demand ahead of the consumption-tax increase.」
While the year-on-year decline continued, signs of changing demand emerged recently, partly due to front-loaded demand associated with the consumption-tax increase. - FY2020-Q1Concerns about a post-consumption-tax-hike backlashAnnual report
「In the domestic eyewear retail market (prescription eyewear), sales were up year on year in September 2019 due to front-loaded demand ahead of the consumption-tax increase, but demand fell back after the tax increase from October, and future trends require close monitoring.」
In addition to the previous explanation of market weakness, this disclosure identifies front-loaded demand before the consumption-tax increase and a subsequent backlash from October as new market fluctuation factors. - FY2019-Q2RestatedAnnual report
「In addition, the domestic eyewear retail market (prescription eyewear) has continued to decline year on year since March 2016 and remains weak.」
The year-on-year decline and weakness in the domestic eyewear retail market continued in the second quarter. - FY2019-Q1RestatedAnnual report
「In addition, the domestic eyewear retail market (prescription eyewear) has continued to decline year on year since March 2016 and remains weak.」
The year-on-year decline and weakness in the domestic eyewear retail market continued as of November 2018. - FY2018WorsenedAnnual report
「In addition, the domestic eyewear retail market (prescription eyewear) has continued to decline year on year since March 2016 and remains weak.」
Unlike the signs of recovery noted in the previous quarter, the full-year disclosure states that the year-on-year decline and weakness continued. - FY2018-Q3MitigatedAnnual report
「The domestic eyewear retail market (prescription eyewear) has recovered from its continuing year-on-year decline since March 2016, with signs of improvement recently.」
The continuing year-on-year decline has begun to recover, indicating signs of improvement in the risk of weakness in the domestic eyewear retail market. - FY2018-Q2RestatedAnnual report
「The domestic eyewear retail market (prescription eyewear) has continued to decline year on year since March 2016 and remains weak.」
The year-on-year decline and weakness in the domestic eyewear retail market continued in the second quarter. - FY2018-Q1RestatedAnnual report
「The domestic eyewear retail market (prescription eyewear) has continued to decline year on year since March 2016 and remains weak.」
The year-on-year decline and weakness in the domestic eyewear retail market continued. - FY2017RestatedAnnual report
「In addition, the domestic eyewear retail market (prescription eyewear) has continued to decline year on year since March 2016 and has remained weak.」
The year-on-year decline and weakness in the domestic eyewear retail market continued throughout the year. - FY2017-Q3RestatedAnnual report
「In addition, the domestic eyewear retail market (prescription eyewear) has continued to decline year on year since March 2016 and has remained weak recently.」
The year-on-year decline and weakness in the domestic eyewear retail market continued in the third quarter. quantified: false; materialized: true. - FY2017-Q2RestatedAnnual report
「In addition, the domestic eyewear retail market (prescription eyewear) has continued to decline year on year since March 2016 and has remained weak recently.」
The year-on-year decline and weakness in the domestic eyewear retail market continued in the second quarter. quantified: false; materialized: true. - FY2017-Q1RestatedAnnual report
「In addition, the domestic eyewear retail market (prescription eyewear) has continued to decline year on year since March 2016 and has remained weak recently.」
The year-on-year decline and weakness in the domestic eyewear retail market continued in the first quarter. - FY2016WorsenedAnnual report
「Meanwhile, the domestic eyewear retail market (prescription eyewear) has continued to decline year on year since March 2016 and has remained weak recently.」
The weakness observed at the quarterly stage continued throughout the year, with the risk discussion expanding to a structural explanation that sustained market expansion cannot be expected as the market matures. - FY2016-Q3First statedAnnual report
「The domestic eyewear retail market (prescription eyewear) has remained weak recently, declining year on year for 3 consecutive months since March 2016 as domestic consumer sentiment deteriorated.」
States that domestic consumer sentiment deteriorated and that the market declined year on year for 3 consecutive months.